NCT02532569 - Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL

Japanese encephalitis vaccine

Dosage and administration: After reconstitution with 0.7 mL of the provided diluent, 0.5-mL dose is administered subcutaneously in the lateral aspect of the upper arm.

Trial Locations (9)

Unknown

Wonju Sevrance Christian Hospital, Wŏnju

Inje University Ilsan Paik Hospital, Goyang-si

Gachon University Gil Medical Center, Incheon

Inha University Hospital, Incheon

Ewha Womans University Mokdong Hospital, Seoul

Korea Cancer Center Hospital, Seoul

KyungHee University Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul